PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Cancer Research, Centre for Cancer Drug Discovery, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.\', \'Autolus Therapeutics Plc, 58 Wood Lane, London, W12 7RZ, UK.\', \'National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Hertfordshire, EN6 3QG, UK.\', \'Quadrucept Limited, 1010 Cambourne Road, Cambridge, CB23 6DW, UK.\', \'Institute of Cancer Research, Centre for Cancer Drug Discovery, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. Electronic address: terry.rabbitts@icr.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(21)00137-610.1016/j.antiviral.2021.105147
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 34375715
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
?:title
  • A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all